TP53 and neoplasm: Another study on human pancreatic ductal adenocarcinoma (PDAC) cells showed that TQ dose-dependently arrested the G2 cell cycle phase and reduced cell growth and viability, increased p53 and p21 expression, and decreased Bcl-2 expression, leading to tumor size reductions [91].